Difficulty: Medium
Average Score: 64%
Testbank
A nurse is caring for a patient who has a diagnosis of acute leukemia. What assessment most directly addresses the most common cause of death among patients with leukemia?
Correct answer
A
Rationale
Monitoring for infection directly addresses the most common cause of death among patients with leukemia, which is infection due to immunosuppression.
Patients with acute leukemia often undergo treatments that compromise their immune systems, making them highly susceptible to infections. Regularly monitoring for signs of infection allows for early intervention, which is crucial in preventing severe complications and mortality associated with infections in this vulnerable population.
B: Monitoring nutritional status does not directly correlate with the immediate risk of infection, which is the primary concern in leukemia patients. While nutrition is important for overall health, it is not the most pressing issue in this context.
C: Monitor electrolyte levels is not focused on infection risk; instead, it addresses metabolic imbalances that may arise from treatment or the disease itself. These imbalances are significant but secondary to the threat of infection.
D: Monitoring liver function is essential for assessing the effects of treatment and the disease but does not directly relate to the risk of infection, which is the leading cause of mortality in leukemia patients.
Patients with acute leukemia often undergo treatments that compromise their immune systems, making them highly susceptible to infections. Regularly monitoring for signs of infection allows for early intervention, which is crucial in preventing severe complications and mortality associated with infections in this vulnerable population.
B: Monitoring nutritional status does not directly correlate with the immediate risk of infection, which is the primary concern in leukemia patients. While nutrition is important for overall health, it is not the most pressing issue in this context.
C: Monitor electrolyte levels is not focused on infection risk; instead, it addresses metabolic imbalances that may arise from treatment or the disease itself. These imbalances are significant but secondary to the threat of infection.
D: Monitoring liver function is essential for assessing the effects of treatment and the disease but does not directly relate to the risk of infection, which is the leading cause of mortality in leukemia patients.